Bank of New York Mellon
OM icon

Bank of New York Mellon’s Outset Medical OM Stock Holding History

Bank of New York Mellon’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Sell
27,899
-34,461
-55% -$151K ﹤0.01% 4190
2026
Q1 		$239K Buy
62,360
+2,435
+4% +$9.98K ﹤0.01% 3936
2025
Q4 		$222K Buy
59,925
+17,892
+43% +$153K ﹤0.01% 3981
2025
Q3 		$594K Buy
42,033
+2,176
+5% +$33.9K ﹤0.01% 3498
2025
Q2 		$766K Buy
+39,857
New +$622K ﹤0.01% 3269
2024
Q3 		– Sell
-33,025
Closed -$1.91M – 4149
2024
Q2 		$1.91M Sell
33,025
-18,410
-36% -$902K ﹤0.01% 2816
2024
Q1 		$1.71M Sell
51,435
-3,645
-7% -$185K ﹤0.01% 2846
2023
Q4 		$4.47M Sell
55,080
-6,107
-10% -$497K ﹤0.01% 2430
2023
Q3 		$9.99M Sell
61,187
-1,875
-3% -$443K ﹤0.01% 1943
2023
Q2 		$20.7M Sell
63,062
-507
-0.8% -$155K ﹤0.01% 1536
2023
Q1 		$17.5M Sell
63,569
-1,313
-2% -$482K ﹤0.01% 1618
2022
Q4 		$25.1M Sell
64,882
-1,217
-2% -$343K 0.01% 1411
2022
Q3 		$15.8M Buy
66,099
+7,695
+13% +$2.06M ﹤0.01% 1635
2022
Q2 		$13M Sell
58,404
-4,566
-7% -$1.96M ﹤0.01% 1788
2022
Q1 		$42.9M Buy
62,970
+14,357
+30% +$8.64M 0.01% 1201
2021
Q4 		$33.6M Buy
48,613
+19,236
+65% +$14.2M 0.01% 1403
2021
Q3 		$21.8M Buy
29,377
+19,805
+207% +$13.5M ﹤0.01% 1680
2021
Q2 		$7.18M Buy
9,572
+6,930
+262% +$5.3M ﹤0.01% 2309
2021
Q1 		$2.15M Buy
2,642
+249
+10% +$192K ﹤0.01% 2886
2020
Q4 		$2.04M Buy
2,393
+2,059
+616% +$1.59M ﹤0.01% 2833
2020
Q3 		$250K Buy
+334
New +$274K ﹤0.01% 3774

Other funds holding OM

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
CFM
Catalyst Funds Management Sydney NSW, Australia $1.78B AUM 107.3% 1-Year Est. Return
RS
R Squared Central, Hong Kong $190M AUM 25.89% 1-Year Est. Return

Bank of New York Mellon's OM Position: Q2 2026 in Review

Bank of New York Mellon reduced its Outset Medical (OM) stake by 55% in Q2 2026, selling an estimated $151K and leaving 27,899 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #4190.

Bank of New York Mellon first reported a position in OM in Q3 2020 and has held it in 21 quarters since. The position peaked at $42.9M in Q1 2022. 34 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Bank of New York Mellon held 27,899 shares of Outset Medical worth $121K as of Q2 2026.
  • Bank of New York Mellon sold 34,461 Outset Medical shares in Q2 2026, an estimated $151K.
  • Outset Medical made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4190 holding.
  • Bank of New York Mellon first reported a position in Outset Medical in Q3 2020 and has held it in 21 quarters since.
  • Bank of New York Mellon's Outset Medical position peaked at $42.9M in Q1 2022.
  • 34 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.